According to the European Society for Medical Oncology (ESMO) guidelines [20], females identified with having mutations in BRCA1, BRCA2, or other high-penetrance genes should initiate breast cancer prevention education from the age of 18, maintain vigilant awareness of breast conditions, and comply with regular medical check-ups. This evidence concerns the gene BRCA1 and breast carcinoma.